Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations

Luiz F. Ybarra, Stéphane Rinfret, Emmanouil S. Brilakis, Dimitri Karmpaliotis, Lorenzo Azzalini, J. Aaron Grantham, David E. Kandzari, Kambis Mashayekhi, James C. Spratt, Harindra C. Wijeysundera, Ziad A. Ali, Christopher E. Buller, Mauro Carlino, David J. Cohen, Donald E. Cutlip, Tony De Martini, Carlo Di Mario, Andrew Farb, Aloke V. Finn, Alfredo R. GalassiC. Michael Gibson, Colm Hanratty, Jonathan M. Hill, Farouc A. Jaffer, Mitchell W. Krucoff, William L. Lombardi, Akiko Maehara, P. F.Adrian Magee, Roxana Mehran, Jeffrey W. Moses, William J. Nicholson, Yoshinobu Onuma, Georgios Sianos, Satoru Sumitsuji, Etsuo Tsuchikane, Renu Virmani, Simon J. Walsh, Gerald S. Werner, Masahisa Yamane, Gregg W. Stone, Stéphane Rinfret, Gregg W. Stone

Research output: Contribution to journal › Article › peer-review

135 Scopus citations

Sort by
Weight
Alphabetically

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations

Fingerprint

Medicine & Life Sciences